CIK 0001326110
- Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 431979754
- Phone
- +1 844-696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes CEO & President gave up 43,165 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 22,094 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 26,835 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 13,470 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Financial Officer gave up 10,511 shares (to pay taxes)
- 4 Shares withheld for taxes CEO & President gave up 17,096 shares (to pay taxes)
- 4 Option exercise Chief Accounting Officer acquired 21,030 shares (option exercise)
- 4 Other acquisition See remarks acquired 209,291,936 shares (other)
- 4 Option exercise Chief Financial Officer acquired 70,744 shares (option exercise)
- 4 Option exercise Chief Accounting Officer acquired 32,872 shares (option exercise)
- 4 Option exercise Director acquired 57,199 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Accounting Officer acquired 21,030 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 13 · 251 filings